Links from MedGen
Items: 14
| Variation | | Type (Consequence) | Condition | Classification, Review status |
---|
| | | Variation | Inflammatory skin and bowel disease, neonatal, 2 | |
| | | Variation | Inflammatory skin and bowel disease, neonatal, 2 | |
| | | Single nucleotide variant (missense variant) | Inflammatory skin and bowel disease, neonatal, 2 | |
| | | Single nucleotide variant (missense variant +1 more) | EGFR-related lung cancer +2 more | |
| | | Single nucleotide variant (intron variant) | not provided +1 more | |
| | | Single nucleotide variant (synonymous variant) | Inflammatory skin and bowel disease, neonatal, 2 +2 more | |
| | | Single nucleotide variant (missense variant) | Inflammatory skin and bowel disease, neonatal, 2 +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Inflammatory skin and bowel disease, neonatal, 2 +4 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +4 more | |
| | | Single nucleotide variant (missense variant) | EGFR-related lung cancer | |
| | | Single nucleotide variant (missense variant) | Inflammatory skin and bowel disease, neonatal, 2 +2 more | |
| | | Single nucleotide variant (missense variant) | not specified +4 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +6 more | |
| | EGFR, EGFR-AS1 (T790M +3 more) | Single nucleotide variant (non-coding transcript variant +1 more) | erlotinib response - Efficacy +2 more | |
Click to view in NCBI Gene